Innovations Spotlight

For media inquiries, please contact innovations@ccf.org

HDL Quality Over Quantity in Prediction of Major Adverse Cardiac Events

07/30/2019

HDL Quality Over Quantity in Prediction of Major Adverse Cardiac Events

Jonathan Smith, PhD, is the Geoffrey Gund Endowed Chair for Cardiovascular Research at Lerner Research Institute. With Cleveland Clinic since 2002, Smith has made major strides in his work toward cardiovascular excellence. Smith’s latest project involves an ApoA1 Exchange Rate Assay as a Diagnostic tool for Major Adverse Cardiovascular Events (MACE).


The Changing Role of Consumerization in Healthcare

07/29/2019

The Changing Role of Consumerization in Healthcare

Let’s face it: Patients are taking a greater role in their healthcare and are demanding more. More access to caregivers, more transparency, more data, more options. Today, we don’t have time to schedule an appointment for three months from now; we want to be seen in 30 minutes.


Ventures-Investment-Innovations Team Rides in Velosano

07/29/2019

Ventures-Investment-Innovations Team Rides in Velosano

Congratulations to all of the riders, volunteers and donors from the CC Ventures Investment Innovation Velosano team who took part in the ride for the cure over July 20-21. This was an impressive showing with nearly 100% participation from all three departments. We had 36 riders ride 2,032 miles over the weekend


Temporal Importance in the Reinvention of Radiation Therapy

07/18/2019

Temporal Importance in the Reinvention of Radiation Therapy

Jacob Scott, MD, DPhil, of Lerner Reserach Institute is not your average doctor. In his every day practice, Dr. SCott leverages a multi-dimensional background. From his time studying astrophysics and nuclear engineering while working aboard a submarine, he utilizes his expertise in computer science and mathematical biology to improve patient care. With two innovative technologies, Jacob looks to maximize radiation therapy efficacy and minimize toxicity in his patients.


O’Neill Testifies in Front of Senate Judiciary Committee

07/17/2019

O’Neill Testifies in Front of Senate Judiciary Committee

In early June in Washington, D.C., Cleveland Clinic Innovations (CCI) Executive Director Pete O’Neill testified in front of a Senate Judiciary Committee on the state of patent eligibility in America. One of 45 witnesses across three days of testimony, O’Neill spoke to Cleveland Clinic’s perspective on the importance of having confidence that an issued patent that follows guidance of the USPTO will not be invalidated based on court case-law.  His testimony addressed Cleveland Clinic’s experience with patenting the diagnostic MPO test, which led to the creation of Cleveland HeartLab. Specifically, he spoke about cases before federal district courts whereby the court rulings resulted in losing the protection of the MPO patents.


AI and the Evolving Nature of Drug Discovery

07/11/2019

AI and the Evolving Nature of Drug Discovery

In turning molecules into medicines, most studies report success 1 out of 10 tries. Yet rapid discovery and development of safe, effective drugs is crucial to moving the needle in healthcare. With unlimited chemical combinations, discovering new candidate medicines is a lengthy, intricate process. Post discovery, drug development is also slow. Undoubtedly, medications require careful progression from bench to bedside to prevent oversight and harm in the ultimate consumers. But with the goal of breakthrough treatments for all conditions, trending HIT applications just might get equally safe medication to the hands of patients sooner. 


A Story of Sweat and Perseverance

07/01/2019

A Story of Sweat and Perseverance

Jill Byrne, RN, MSN, knows a thing or two about persistence. Since 2010, she has been working diligently – and doggedly – to bring her invention to life.


Learn How Nontraditional Companies are Changing Healthcare at MIS2019

06/25/2019

Learn How Nontraditional Companies are Changing Healthcare at MIS2019

The pace of innovation in healthcare is accelerating, with words like “disruption” and “digital transformation” frequently used to describe changes happening in healthcare.  Other industries are also experiencing rapid changes, and some companies in these other industries are looking to apply their new products and processes to healthcare, in disruptive ways.  At MIS2019 will bring together innovation leaders from companies in other industries, to share how their companies prospered during their rapid innovation and how they are looking to grow their participation in healthcare. 


Murata and Cleveland Clinic Expand Relationship

06/25/2019

Murata and Cleveland Clinic Expand Relationship

Nearly two years ago, Cleveland Clinic Innovations and Murata Electronics, a Japanese manufacturer of electronic components, entered into a collaboration agreement to identify potential opportunities to jointly develop novel medical technologies. Last month, both organizations agreed to expand the relationship as Murata formally joined Cleveland Clinic’s Healthcare Innovation Alliance program.


It

06/24/2019

It's Time to Get AMP'D!

AMP’D Arena, at the 2019 Medical Innovation Summit, will feature 40 innovative startup companies that are leading the way in best-in-class healthcare technology poised to impact the way we care for patients, caregivers and the community everywhere.


 <  6 7 8 9 10 11 12 13 14 15  > 

Get In Touch With Us